Topic: Genetic Testing

How Genomic Profiling Increases Cancer Patients’ Chances of Survival!

Published by on October 3, 2018 | Share your thoughts

In nearly a decade of helping people recover from cancer, CTOAM’s precision oncology specialists have never seen two people with exactly the same cancer. Our specialists have seen people with breast, lung, brain, and prostate cancer, as well as other types of cancer – and, even within the same category, no two people have had the exact same mutations driving their cancer. Therefore, each of our patients has required a unique combination of advanced targeted therapies and nutraceuticals, and sometimes in addition to other treatment interventions. In order to have the best chance of recovery from cancer, your treatment must target your unique genetic mutations. And for that, you need genomic profiling and Precision Oncology’s gene-based approach to cancer care. What is Cancer? Cancer is...
Read Article


How Genomic Profiling is Guiding Cancer Treatment

Published by on August 20, 2018 | Share your thoughts

Genomic profiling is approved by the FDA to help guide cancer treatment and clinical trial enrolment for cancer patients. Among other things, this approval allows the genetic test, F1CDx (FoundationOne CDx), to be used as a companion diagnostic test for 15 different targeted therapies used to treat five types of cancer. What is Genomic Profiling for Cancer Treatment? At its most basic, genomic profiling involves testing a patient’s genes – aka tumour DNA sequencing – to identify the exact genetic mutations that are driving that person’s form of cancer. After we identify the person’s genetic mutations, we find a targeted therapy to match. In other words, we find a drug that’s designed specifically to kill the patient’s exact genetic mutations. Not all genetic mutations have...
Read Article